We have determined the high resolution crystal structure of the methyltransferase domain of the NS5 polypeptide from the Murray Valley encephalitis virus. This domain is unusual in having both the N7 and 29-O methyltransferase activity required for Cap 1 synthesis. We have also determined structures for complexes of this domain with nucleotides and cap analogues providing information on cap binding, based on which we suggest a model of how the sequential methylation of the N7 and 29-O groups of the cap may be coordinated.
INTRODUCTION
Eukaryotic mRNA is co-translationally modified (capped) at its 59 end with a methylated GpppN (Gebauer & Hentze, 2004; Shatkin, 1976) . This not only protects mRNA against exonucleases, but is required for the efficient initiation of translation and is involved in processes such as splicing (Gu & Lima, 2005; Parker & Song, 2004) . Cap formation is sequential: firstly the c-phosphate of the terminal base is removed by an RNA triphosphatase, secondly an RNA guanylyltransferase (GTase) couples guanosine monophosphate to the b-phosphate of the terminal base via a 59-59 linkage and thirdly, a methyltransferase (N7MTase) methylates the N7 position of the terminal guanosine. Subsequently the ribose 29-OH position of the second, third and even fourth base (counting from the start of the cap) may be methylated by an 29-OMTase. The methylation reactions use S-adenosyl-L-methionine (AdoMet) as a methyl donor, generating, as a by-product, S-adenosyl-Lhomocysteine (AdoHcy).
Eukaryotic viruses have come up with a variety of ways to produce capped mRNA. Some, including the lentiviruses and herpesviruses, hijack the host capping machinery, others, such as influenza viruses and hantaviruses, 'snatch' cap structures from capped cellular mRNAs, whilst viruses like orbiviruses, orthopoxvirus and flaviviruses encode their own capping enzymes (reviewed in Gale et al., 2000; Schneider & Mohr, 2003) . Little is known about the components of the capping machinery of flaviviruses, such as dengue virus and West Nile virus. The capped positivesense, single-stranded RNA genome is translated as a single polyprotein that is processed by cellular and viral proteases into three structural and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Chambers et al., 1990) . Although the guanylyltransferase has yet to be identified, the other activities required for cap formation have been mapped to non-structural proteins: RNA triphosphatase activity to NS3 (Bartelma & Padmanabhan, 2002; Kuo et al., 1996; Warrener et al., 1993; Wengler, 1993) , 29-OMTase activity to the Nterminal domain of the RNA-dependent RNA polymerase, NS5 (Egloff et al., 2002; Ray et al., 2006) , and, most recently, N7MTase activity to the same domain (Ray et al., 2006) . The crystal structure of the NS5 MTase domain of dengue virus type 2 (Egloff et al., 2002) shows structural similarity to the vaccinia virus VP39 and orthoreovirus l2 29-OMTase domains (Bujnicki & Rychlewski, 2001; Hodel et al., 1996; Reinisch et al., 2000) . However, crystal soaking experiments with a non-hydrolysable guanosine triphosphate (GTP) analogue and ribavirin 59-triphosphate, a competitive inhibitor (Benarroch et al., 2004) , showed binding at a site distinct from the 'conventional' capbinding site observed previously in several cap-binding proteins (Calero et al., 2002; Fechter & Brownlee, 2005; Hodel et al., 1997; Marcotrigiano et al., 1997) . Conventional binding sandwiches the m7 guanosine in between two aromatic side chains, achieving ring stacking. In contrast, in the dengue virus MTase structure the nucleotide analogue was stacked against a single aromatic side chain (F25) in a shallow depression on the surface of the protein, some 10 Å (1 nm) from the equivalent m 7 GTP-binding site in vaccinia virus VP39, so it remained unclear as to how methylation of either N7 or 29-O groups might occur and, to date, no structural information has been available on the binding of cap analogues or capped RNA, to a flavivirus NS5.
We report here the 2 Å (0.2 nm) resolution crystal structure of the NS5 MTase domain of Murray Valley encephalitis virus (MVEV). MVEV is a member of the Japanese encephalitis group of flaviviruses, which includes the West Nile virus. In addition, a number of complexes of this domain with nucleotides and cap analogues have been determined at approaching 2 Å (0.2 nm) resolution, in an attempt to understand cap binding and throw light on the mechanism of both N7 and 29-O methylation. In particular, a crystallographic dimer of the MTase domain in complex with GpppA suggests a paradigm for the coordination of the sequential methylation of the terminal guanosine N7 and the second ribose 29-OH position.
METHODS
Cloning and expression. A set of six constructs with different Cterminal domain boundaries was designed using criteria described in the results section and cloned using the Oxford Protein Production Facility (OPPF) high throughput pipeline into an In-Fusion-adapted pTriEx 2 vector, pOPINE [InFusion technology (BD Bioscience) (Aricescu et al., 2006; Berrow et al., 2007) ], adding a C-terminal KHHHHHH tag to the protein (Table 1) . Constructs were PCR amplified using the KOD HotStart polymerase (Merck Biosciences), gel purified using QIAquick 96 plates (Qiagen) and used for InFusion cloning with linearized pOPINE vector. For small-scale expression screening, the recombinant vectors were used to transform Escherichia coli Rosetta(DE3)pLysS. Expression screening was performed in 3 ml GS96 (Q-biogene) cultures in 24-well blocks, supplemented with 50 mg carbenicillin ml 21 , 35 mg chloramphenicol ml 21 and 1 % glucose. Cultures were grown to an OD 600~0 .6 at 37 uC, shaken at 220 r.p.m., the temperature was dropped to 20 uC, IPTG was added to 0.5 mM final concentration and incubated for 16-20 h. Cell pellets were processed on a Qiagen biorobot 8000 using magnetic Ni-NTA beads (Qiagen) to extract his-tagged proteins from the soluble fraction. For large-scale expression, a fresh colony was picked to inoculate an overnight starter culture in Luria-Bertani broth containing 50 mg carbenicillin ml 21 , 35 mg chloramphenicol ml 21 and 1 % glucose at 37 uC, shaken at 220 r.p.m. Then 1 litre of GS96 (Q-Biogene) containing 50 mg carbenicillin ml
21
, 35 mg chloramphenicol ml 21 and 1 % glucose was inoculated with 20 ml of starter culture and grown to an OD~0.6 at 37 uC, shaken at 220 r.p.m., at which point the temperature was dropped to 20 uC, IPTG was added to 0.5 mM final concentration, and incubation continued for 16-20 h at 20 uC.
Protein purification and reductive methylation. Cell pellet was resuspended in 30 ml lysis buffer [50 mM Tris pH 7.5, 500 mM NaCl, 20 mM imidazole, 0.2 % Tween 20 (v/v)] per 10 g of cell paste. All subsequent steps were carried out at 4 uC unless stated otherwise. DNase (Sigma-Aldrich) and protease inhibitors (EDTA-free mini tablet; Roche Applied Science) were added and the slurry passed through a cell disruptor (Basic Z cell disruptor; Constant Systems) at 30 000 psi. Insoluble material was removed by centrifugation in a Beckman JA-17 rotor at 30 000 g. The soluble fraction was filtered and loaded onto an Akta Express purification system (GE Healthcare) mounted serially with a Ni-NTA affinity column (HisTrap FF, 1 ml; GE Healthcare), followed by a gel filtration column (Hiload 16/20, Sephadex 200; GE Healthcare). Buffers were as follows: Ni-NTA wash buffer (25 mM Tris pH 7.5, 500 mM NaCl, 20 mM imidazole), Ni-NTA elution buffer (50 mM Tris pH 7.5, 500 mM NaCl, 500 mM imidazole) and gel filtration buffer (20 mM Tris pH 7.5, 200 mM NaCl or 50 mM HEPES pH 7.5, 250 mM NaCl) for reductive methylation. Peak fractions were pooled and concentrated using a Vivascience concentrator with 10 kDa cut-off membrane. Protein purity was assessed by SDS-PAGE (NuPage 10 % Bis-Tris gels; Invitrogen), followed by SafeStain staining (Invitrogen). The protein mass was verified using liquid chromatography (HPLC; Dionex) and (Nettleship et al., 2005) . Reductive methylation of lysine residues was employed as an aid to crystallization, using the method described elsewhere (Walter et al., 2006) . The extent of methylation was assessed by electrospray mass spectrometry.
Crystallization. Three NS5 constructs (1-293, 1-291 and 1-269) yielded protein of sufficient quality for crystallization trials ( Table 2) . The methylated and unmethylated proteins were concentrated to 3 mg ml 21 (NS5 1-293 native), 2.6 mg ml 21 (NS5 1-293 methylated), 6 mg ml 21 (NS5 1-291 native and methylated), 9 mg ml 21 (NS5 12269 native) and 6 mg ml 21 (NS5 1-269 methylated). Crystallization trials were set-up in the presence or absence of 0.5 mM AdoHcy and monitored using the OPPF crystallization and imaging pipeline Walter et al., 2005) . Useful crystals of NS5 1-269 were only obtained for methylated protein. These appeared after 24 h in a large number of conditions in the Hampton PEG/Ion screen and Hampton crystal screens 1 and 2 (Hampton Research). Crystallization conditions for crystals used to collect data are given in Table 2 (all X-ray data were collected at the ESRF, Grenoble, France). In addition data were collected for m 7 GTP (Sigma-Aldrich) soaked methylated NS5 1-269 and for methylated NS5 1-269 co-crystallized with a cap analogue at 2 : 1 molar ratio [P1-P3 diguanosine triphosphate (GpppG); Sigma]. Subsequently, it was found that non-methylated NS5 1-269 in the presence of 0.5 mM AdoMet co-crystallized with either GpppA or m 7 GpppA (New England Biolabs) (cap analogue to protein ratio 2 : 1). The best crystals were with GpppA analogue, for which a dataset was collected. Crystallization condition: Hampton Crystal Screen 2 (22); 12 % (w/v) polyethylene glycol 20 000, 0.1 M MES pH 6.5. #Number of molecules in the asymmetric unit. **R work and R free are defined by R5S hkl ||F obs |2|F calc || / S hkl |F obs |, where h, k, l are the indices of the reflections (used in refinement for R work ; 5 %, not used in refinement, for R free ), F obs and F calc are the structure factors, deduced from measured intensities and calculated from the model, respectively. DDMean B-factor for main chain, side-chain, water and other atoms.
X-ray data collection and structure determination. Images were collected as 1u oscillations from crystals maintained at 100 K, and processed using HKL2000 (Otwinowski & Minor, 1997) (Table 2) . Crystals were flash frozen in 25 % glycerol diluted using the crystallization solution. In addition for cap analogue soaking experiments, the analogue was present in the cryo-solution at a concentration no less than that in the soaking solution. Crystals of the first NS5 MTaseAdoHcy complex (form 1) belonged to space group P2 1 with unit cell dimensions a546.4 Å (4.64 nm), b568.3 Å (6.83 nm), c582.0 Å (8.2 nm), b598.4u and contained two molecules in the crystallographic asymmetric unit. The structure was solved by molecular replacement using the structure of dengue virus NS5 MTase domain [Protein Data Bank (PDB) id. 1L9K] with CNS (Brunger et al., 1998) . The model was automatically rebuilt with ARP/WARP (Perrakis et al., 1999) and refinement at 2 Å (0.2 nm) completed using REFMAC (Murshudov et al., 1997) . The current model, comprising 256 residues, has an R-factor of 0.200 (R-free 0.273) and good stereochemistry (93.6 % of residues lie in the most favoured region of the Ramachandran plot, Table 2 ). The remaining five structures were solved by molecular replacement from these coordinates and refined using similar procedures (Table 2) .
RESULTS

Crystallization of the NS5 methyltransferase domain
The construct equivalent to that which yielded the structure of the dengue virus type 2 MTase [MVEV NS5 1-297 , Egloff et al. (2002) ] failed to yield crystals, so five shorter constructs differing in the choice of the C terminus were assessed (Table 1) . These constructs were truncated on the basis of RONN disorder predictions (Yang et al., 2005) and/ or the presence of regions of lower sequence conservation amongst the flaviviruses. MVEV NS5 1-269 maps to the portion of the dengue virus NS5 MTase domain visible in the study by Egloff et al. (2002) . Small-scale expression screening demonstrated that most constructs were expressed in E. coli, albeit with significantly differing levels of soluble expression (compare NS5 1-269 and NS5 1-272 , Table 1 ). Crystallization trials with NS5 1-291 , NS5 1-293 and NS5 1-269 yielded no crystals suitable for diffraction analysis, either in the presence or absence of AdoHcy. However, methylation of NS5 1-269 (adding two methyl groups to accessible lysine residues and to the N terminus) yielded crystals in a variety of conditions in the presence of AdoHcy. Mass spectrometry analysis revealed that 18 out of the 21 potential sites had been methylated. In contrast, despite their improved appearance, crystals of methylated NS5 1-291 and NS5 1-293 remained unsuitable for diffraction analysis. Subsequent experiments showed that non-methylated NS5 1-269 could be crystallized in the presence of both a cap analogue (GpppA) and AdoMet.
Overall architecture and comparison with related structures
Three crystal forms of the MTase domain of NS5 in complex with AdoHcy have been solved, giving five independent views of the molecule. All five molecules are essentially identical in structure [pairwise root-meansquare deviations (rmsds) between 0.3 (0.03) and 0.5 Å (0.05 nm) for all Ca atoms], and amongst known structures they are most similar to the MTase domain of dengue virus NS5 [248 Cas matched with rmsd 0.7 Å (0.07 nm), using program SHP (Stuart et al., 1979) , Fig. 1 ]. The structure has the characteristic class I methyltransferase fold (Martin & McMillan, 2002; Schubert et al., 2003) , with N-terminal (helices A1-A3, Fig. 1 ) and C-terminal (helix A4-end) extensions (nomenclature of Egloff et al., 2002) . As in the dengue virus MTase domain, helix aB, between strands b2 and b3 is essentially a single turn and aC (which would lie between b3 and b4), is entirely absent. One difference between the dengue virus and MVEV structures is that the end of helix A3 and the following loop (43-49) is ordered in only two of the five MVEV MTase domain structures (where it is stabilized by either crystal contacts or the presence of a cap analogue).
MVEV MTase domain was crystallized in the presence of product AdoHcy, which was clearly visible in electron density maps, bound in the site described for dengue virus that contains motifs typical of AdoMet-binding proteins: a glycine-rich motif located between aA and b1, which interacts with the amino acid portion of AdoMet, and an acidic loop connecting b2 with aB, interacting with the ribose hydroxyls (Fig. 1a) . The adenosine ring is bound in a hydrophobic pocket, sandwiched between I147 and the aliphatic component of K105. Although K105 is involved in binding AdoHcy, it is clear from the electron density map that it has been methylated. The conformations of the bound AdoHcy molecule and interacting side chains are essentially identical between the dengue virus and MVEV MTase domains, with the exception of two side chains that are perturbed in dengue virus by the presence of a sulphate ion, which interacts with the ribose hydroxyls (in MVEV residue E111 rearranges to hydrogen bond to the 39 ribose hydroxyl group and H110 moves to coordinate the 29-O group). The KDKE tetrad, characteristic of 29-OMTase active sites is conserved in MVEV MTase (K61, D146, K182, E218), and superposes well on the equivalent residues of the 29-OMTases of dengue virus (NS5; PDB id. 1L9K), vaccinia virus (VP39; PDB id. 1AV6) and reovirus (PDB id. 1EJ6, A434-A691).
Structurally, the MVEV MTase domain is more similar to 29-OMTase domains than to N7MTase domains; however, functional studies suggest that flavivirus NS5 possesses both activities (Ray et al., 2006) . Superposition of this domain and the Ecm1 N7MTase (from the microsporidian parasite Encephalitozoon cuniculi, PDB id. 1Rl1; Fabrega et al., 2004) aligns the conserved seven-stranded core of the class I methyltransferases [matching 188 Cas with 2.4 Å (0.24 nm) rmsd, Fig. 2 ]. The AdoMet substrate is similarly positioned in the two structures, although the contacting helices and loops differ. A significant difference between the two structures is an extra domain (175-229 in the Ecm1 numbering scheme) inserted into the class I fold in Ecm1 at residue 185 in MVEV NS5. This small domain appears to stabilize the binding of the cap structure, closing around the GTP so that it is positioned to accept the methyl group from the AdoMet substrate. The electron density maps for the co-crystal structure of Ecm1 N7MTase with m 7 GpppG revealed only GTP, suggesting a preferential binding for unmethylated GTP (Fabrega et al., 2004) .
Complex with m 7 GTP and GpppG
The crystal structure of MVEV NS5 bound to m 7 GTP shows similarity with the nucleotide-analogue bound MTase domain of dengue virus, with several key interactions conserved (Fig. 3a) . The guanosine stacks against the residue F24 with the methylated N7 exposed to solution and not directly in contact with the protein. Base specificity is achieved through electrostatic interactions between the N2 of the base and the carbonyl oxygens of residues L16 and M19. The ribose hydroxyl groups are contacted by residues N17 and K13. The latter forms hydrogen bonds with both hydroxyls (the electron density map shows no evidence of methylation), whereas N17 only contacts the 29-O group. In addition the conformation of the loop containing residues S150 and P152 that packs against the sugar is identical in both proteins. Additional contacts are observed between residues R28, S215, R213 and the triphosphate group.
The co-crystal structure with GpppG is very similar to that of m 7 GTP; the second guanine (base and ribose) being disordered (Fig. 3b) . The base and ribose groups of the first guanine are bound in an identical manner to m 7 GTP, but the conformation of the triphosphate groups differs slightly, presumably due to the disorder in the second guanine. The R213 contact becomes, here, a water-mediated hydrogen bond and the S215 contact is lost altogether. (Egloff et al., 2002) . The core class I methyltransferase is indicated by the yellow bar, while the N-and C-terminal extensions are defined by the red and cyan bars, respectively. Secondary structural elements as defined by Kabsch & Sander (1983) are represented by conventional symbols and conserved residues highlighted by red blocks. The residues highlighted in panel (a) are marked with triangles.
Complex with GpppA and AdoMet: a model for methylation
Unlike the other nucleotide/cap analogue complexes, the GpppA-AdoMet co-crystal structure reveals a crystallographic dimer of the methyltransferase domain, with two GpppA molecules bound per monomer (see Fig. 3c ). One (GA1) binds at the same position as GpppG and m 7 GTP and the second (GA2) binds adjacent to it, interacting with positively charged residues near the AdoMet-binding cleft. The two molecules interact, with the adenosine base of GA1 stacked against the guanosine base of GA2. GA1 and GA2 are further stabilized by a complex set of twofold interactions generated by the crystallographic twofold axis, in particular for GA2, which lies adjacent to this axis. In total this association sandwiches eight bases between the two monomers and effectively spans the two crystallographically related GTP-binding sites (details of the interactions are provided in Fig. 3c) . Surprisingly, although AdoMet is bound in an identical fashion to that described above for the product AdoHcy, none of the moieties in either GA1 or GA2 that would be methylated by either the N7 or 29-O methyltransferase activities are in a catalytically competent position. The closest 29-O group to the AdoMet belongs to GA1, but is over 10 Å (1 nm) from the leaving methyl group. Comparison with vaccinia virus VP39 complexed to capped RNA (Hodel et al., 1998) suggests that helix A3 binds the incoming RNA, which might explain the binding of the second GpppA in a similar position. Why only a single, partly ordered GpppG was observed is not clear, but could be related to the adenosine-specific effects on binding/ stacking, or possibly because methylated protein was used in the NS5 1-269 -GpppG complex, whereas for the GpppA complex native protein was used (although no lysines interact with GA2).
DISCUSSION
The two methyltransferase reactions required for cap-1 synthesis are usually performed by separate proteins, or at least by separate domains of a larger protein (for example in vaccinia virus the N7 reaction is performed by the heterodimeric mRNA capping enzyme D1/D12, and the 29-O reaction by VP39, part of the polyadenylate polymerase heterodimer VP39/VP55 (Cong & Shuman, 1992; Moure et al., 2006) . However, a recent biochemical study suggests that NS5 of flaviviruses can perform, sequentially, both N7 and 29-O methylation, but only in the presence of appropriate viral RNA (Ray et al., 2006) . Our analysis confirms the binding site for the m 7 GTP component of the cap structure observed by Egloff et al. (2002) , and a complex with GpppG reveals that the second guanosine moiety is disordered. Although we have been unable to capture a catalytically relevant binding state, the presence of eight bases lining the dimer twofold interface in the GpppA complex suggests a model for the interaction of viral RNA, which explains why it is required for activity and also suggests a novel mechanism for coordinating the sequential capping. We note that our dimer differs significantly from that observed by Egloff et al. (2002) (superposing the one of the two monomers of the dengue virus MTase domain and MVEV domains leads to a 120 u difference in orientation for their dimeric partners); furthermore PISA (Krissinel & Henrick 2005) suggests that, unlike the dengue virus MTase dimer, the GpppA dimer interface is not extensive enough to be considered physiologically relevant. However, there are intriguing similarities with the observations of Egloff et al. (2002) , whose dimer interface was cemented by sulphate ions, which have similar properties to the phosphate groups of RNA. Our model for the sequential methylation N7 and 29-O groups of the capped RNA is illustrated schematically in Fig. 4 . We propose that RNA with an unmethylated cap locks into the MTase dimer interface. As it enters, the N7 group of the terminal guanosine is methylated by the first AdoMet molecule encountered. As the cap is pushed further in, the terminal methylated guanosine binds at the GTP site (Phe-24), and the second AdoMet molecule is then positioned to methylate the 29-O group of the second ribose. The products, fully methylated capped RNA and AdoHcy, are then released, allowing substrate AdoMet to rebind, priming the dimer for the next dual methylation cycle. Note that, due to the symmetry of the molecular dimer, cap can enter in either direction Fig. 1(b) , are omitted for clarity. The AdoHcy product and GTP substrate for Ecm1 are modelled as sticks and coloured green, and the AdoHcy product for MVEV coloured yellow.
(presumably from either polymerase domain) and still be methylated in the correct sequence. Despite the attractive features of this paradigm, there are still many outstanding questions, thus whilst NS5 in solution is monomeric, it is not clear what the oligomeric state of NS5 is during replication. There are also additional complexities to the capping process, for instance dengue virus NS3 and NS5 form a replication complex (Yon et al., 2005) . One of the domains of NS3 has RNA stimulated nucleoside triphosphatase and 59 triphosphatase activity and may play a role in cap synthesis; however, the molecular species responsible for the guanylyltransferase activity remains unknown. In addition, the proper positioning for the first, N7, reaction may be facilitated by the recognition of a specific 59 RNA element adjacent to the cap (in dengue virus named SLA), by the NS5 polymerase domain (Filomatori et al., 2006) . In summary, although our model for cap binding and methylation is speculative, it explains cogently how N7 methylation and 29-O methylation would be highly coupled. Initially, cap is bound in a position defined approximately by the position of GTP in the Ecm1 N7MTase complex, with RNA or protein helping to reconfigure the protein to, at least transiently, stabilize the cap in this relatively low GTP with its difference electron density map, calculated using data to 2.0 Å (0.2 nm) and contoured at 3.0s. Surrounding protein is shown in cartoon representation coloured as in Fig. 1(a) . The side chains of interacting residues are modelled as sticks. (b) Comparison of the binding of m 7 GTP (cyan) and the ordered component of GpppG (red) to MVEV NS5 1-269 . The other figure elements are as in Fig. 1(a) . (c) Difference electron density for GpppA co-crystallized with MVEV NS5 1-269 and AdoMet, calculated using data to 2.8 Å (0.28 nm) and contoured at 2.5s. Two molecules of GpppA (GA1 and GA2, coloured red) and their crystallographically related neighbours (GA1* and GA2*, coloured purple) and AdoMet (orange) are shown modelled into the electron density. Loop 43-49, disordered in some of the crystal structures, is drawn in pink, and marked by a hash symbol ( # ). Other elements are as for Fig. 1(a) . An array of complex interactions stabilize the packing of the four molecules of GpppA between the dimers of NS5 . The guanine base of GA1 packs against F24, as observed in the m 7 GTP and GpppG complexes, but in addition the 69-O group forms an electrostatic interaction with the crystallographically related R42, whilst the adenine base is sandwiched between the guanine base of GA2 and the aliphatic side chain of the twofold related R45. In addition, R41 and R44 from the crystallographically related molecule pack against the guanine of GA2, which in turn packs against the adenine from the crystallographically twofold related GA2. This adenine also interacts with the side chains of R84 and R44. GA2 binding is also mediated by main chain interactions between R37 and R57 and the triphosphate group, whilst the side chains of R84 and E111 contact the ribose hydroxyl groups. affinity site and allow proximity mediated catalysis. Upon methylation at N7, the cap moves along the dimer interface to the position seen in our crystal structures. In the context of the dimer, the second base is then positioned correctly for catalysis with the 29-O group hydrogen bonded to the conserved active site residue K182 and close to the methyl donating group of the AdoMet (as observed in the complex of VP39 with cap-RNA analogue). This model explains why N7 methylation precedes the 29-O reaction, although it leaves open questions such as the role of NS3 in coordinating cap synthesis and how specificity for m 7 GTP is achieved. Fig. 4 . Schematic cartoon illustrating the model for coordinated N7 and 29-O methylation. A dimeric relationship between the MTase domains of NS5 allows the sequential and coordinated methylation of the N7 and 29-O groups by the two AdoMet cofactors. Capped RNA is fed into the groove, stabilizing the interaction between the two MTase domains, where it is methylated by the first AdoMet it encounters (AdoMet 1) at the N7 group of the inverted guanosine base, and subsequently at the ribose 2'-OH position of the second base by AdoMet 2.
